Medica S.p.A. Share Price

Equities

MDC

IT0005460149

Biotechnology & Medical Research

Market Closed - Borsa Italiana 09:14:59 30/04/2024 pm IST 5-day change 1st Jan Change
26.4 EUR 0.00% Intraday chart for Medica S.p.A. 0.00% +70.32%

Financials

Sales 2023 79.98M 85.43M 7.13B Sales 2024 * 93.11M 99.46M 8.3B Capitalization 111M 119M 9.93B
Net income 2023 2M 2.14M 178M Net income 2024 * 6M 6.41M 535M EV / Sales 2023 0.82 x
Net Debt 2023 * 10.35M 11.06M 922M Net Debt 2024 * 5.92M 6.32M 527M EV / Sales 2024 * 1.26 x
P/E ratio 2023 *
55.6 x
P/E ratio 2024 *
16.3 x
Employees 676
Yield 2023 *
-
Yield 2024 *
-
Free-Float 20.07%
More Fundamentals * Assessed data
Dynamic Chart
Current month+56.21%
1 month+52.60%
3 months+65.00%
6 months+46.67%
Current year+70.32%
More quotes
1 week
26.20
Extreme 26.2
26.60
1 month
17.00
Extreme 17
26.60
Current year
14.50
Extreme 14.5
26.60
1 year
14.40
Extreme 14.4
26.60
3 years
14.40
Extreme 14.4
45.80
5 years
14.40
Extreme 14.4
45.80
10 years
14.40
Extreme 14.4
45.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 41 01/11/01
Chairman 75 01/90/01
Chief Administrative Officer 58 01/95/01
Members of the board TitleAgeSince
Director/Board Member 54 14/21/14
Chairman 75 01/90/01
Chief Executive Officer 41 01/11/01
More insiders
Date Price Change Volume
30/24/30 26.4 0.00% 11 400
29/24/29 26.4 0.00% 19,100
26/24/26 26.4 0.00% 950
25/24/25 26.4 -0.75% 500
24/24/24 26.6 +0.76% 1,600

Real-time Borsa Italiana, April 30, 2024 at 09:14 pm IST

More quotes
Medica SpA is an Italy-based company primarily engaged in designing, manufacturing and supplying blood purification systems. Through subsidiaries, such as Tecnoideal sel the Company not only offers dialyzers, ultrafilters, HDF online sets, bloodlines, and pediatric dialyzers for dialysis treatment but also provides critical care CRRT equipment, hemofilter, pediatric filters, C02 removal, apheresis equipment, fractionator-cascade filtration, plasma filters, and leukocyte adsorber. It also supplies Cardiosmart, an integrated system for the treatment of patients affected by congestive heart failure; MediSulfone membrane and Purema hemoconcentration. It is engaged in water purification offering systems, including lab-pharma-industrial filtrations, individual water purifiers, and point-of-use filtrations. The Company provides infusion sets, urodynamic systems, palm bladder scanner and gastroenterology systems, among others. It operates globally.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
26.4 EUR
Average target price
31.4 EUR
Spread / Average Target
+18.94%
Consensus

Annual profits - Rate of surprise